MS Views and News Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -

Visit our MS learning channel on YouTube, which provides hundreds of MS educational videos presented by MS Experts from across the USA. Archived here: www.youtube.com/msviewsandnews -- Also please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for the MS community. Furthermore, scroll down the left side of this blog to learn from the resources and links.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~


Saturday, June 25, 2016

Risk Evaluation of Multiple Sclerosis Medications


                                                                  
  

Click here to receive MS news via e-mail





Published on Jun 3, 2016
Dr. Daniel Kantor talks with Dr. Clyde Markowitz, Associate Professor of Neurology and Director of the MS Center at the Perelman School of Medicine at the University of Pennsylvania, about risk evaluation of Multiple Sclerosis medications.

===================================================

Dr. Markowitz - tells it like it is -- 
     Stu's Views : I enjoyed listening to the questions and the responses





     an MS World presentation

.



MS Views and News
Providing educational information, resources and services for those affected by MS

2 comments:

Joan Quilter said...

Actually, I didn't learn anything new. My daughter spent years on Avonex and other MS drugs,but this didn't stop her MS from progressing until she is now severely disabled.

I thought these doctors would talk a bit about the new monoclonal antibody type drugs for MS because these drugs, really, look dangerous to me.

Why is it that some neurologists say the classic MS drugs slow down progression, while other neurologists say nothing? Both my daughter and my sister, who also has MS, have given up on seeing neurologists. I think that neurologists don't have or make time to keep up with the latest research. I have had to show my daughter's neurologist the latest findings of clinical trials, and these findings were on top of the lists at the latest annual academy of neurologists meeting in Vancouver.

Stuart said...

Joan,
I do not know which Neurologists your daughter or your sister have seen, but I do want to ask if either has seen a MS Specialist. If yes, the specialist would have offered greater detail or more knowledge than it seems your daughter and sister have been told.
Having had the correct physicians, might have enabled one or both to have learned of other MS Medications if they were RRMS patients, True MS Neurologists will tell you that the available FDA approved MS Medications slow the disease course. Some of the medications have higher percentages than others but those too, come with potentially greater side-effects.. "Potentially" being the KeyWord.

BTW -- ALL MS Neurologist (specialists) do keep up with the latest research. It is your general neurologist that may not... To learn of an MS Specialists near you, you can simply contact The National MS Society chapter office nearest you

How could you not have learned something new from the discussion on this video?

The topic for this video is Risk Evaluation of MS Medications.
As for the MAB meds, no names were given during the interview, but well mentioned was "New Medications" - MAB meds are some of these new medications.

POINT made of the conversation in this interview is how the new treatments are discussed with MS neurologists and their patients...... Yes, Patients must discuss the new meds and the risks that 'might' be involved and how this might associate to the disease state of the patient.

Please re-watch / re-listen to this video if you want to understand what was discussed.

As for specific MAB medications - this will be eventually posted as a separate video.

p.s. - disclaimer - note that I am not a medical doctor of any degree and that what I just wrote is my opinion only - regards, Stuart